ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2021)
Historic Cost of Revenue for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $382113.0.
- ENDRA Life Sciences' Cost of Revenue rose 9857.87% to $382113.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 8480.65%. This contributed to the annual value of $571040.0 for FY2024, which is 3040.8% down from last year.
- ENDRA Life Sciences' Cost of Revenue amounted to $382113.0 in Q4 2021, which was up 9857.87% from $275565.0 recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Cost of Revenue ranged from a high of $382113.0 in Q4 2021 and a low of $1124.0 during Q1 2017
- Its 5-year average for Cost of Revenue is $125312.5, with a median of $111066.0 in 2018.
- In the last 5 years, ENDRA Life Sciences' Cost of Revenue tumbled by 7464.47% in 2017 and then soared by 943532.03% in 2018.
- Quarter analysis of 5 years shows ENDRA Life Sciences' Cost of Revenue stood at $3085.0 in 2017, then surged by 1259.09% to $41928.0 in 2018, then skyrocketed by 298.47% to $167070.0 in 2019, then grew by 15.18% to $192424.0 in 2020, then skyrocketed by 98.58% to $382113.0 in 2021.
- Its Cost of Revenue stands at $382113.0 for Q4 2021, versus $275565.0 for Q3 2021 and $256763.0 for Q2 2021.